A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Freedman, S. Ben
Haeusler, Karl Georg
Lane, Deirdre A.
Nielsen, Jens C.
Piccini, Jonathan P.
Sinner, Moritz F.
Tse, Hung Fat
Van Gelder, Isabelle C.
Vardas, Panagiotis E.
Lip, Gregory Y. H.
Camm, A. John
MetadataShow full item record
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more suffer from undiagnosed, subclinical, or silent AF. Atrial fibrillation-related cardiovascular mortality and morbidity, including cardiovascular deaths, heart failure, stroke, and hospitalizations, remain unacceptably high, even when evidence-based therapies such as anticoagulation and rate control are used. Furthermore, it is still necessary to define how best to prevent AF, largely due to a lack of clinical measures that would allow identification of treatable causes of AF in any given patient. Hence, there are important unmet clinical and research needs in the evaluation and management of AF patients. The ensuing needs and opportunities for improving the quality of AF care were discussed during the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference in Nice, France, on 22 and 23 January 2015. Here, we report the outcome of this conference, with a foc...us on (i) learning from our neighbours to improve AF care, (ii) patient-centred approaches to AF management, (iii) structured care of AF patients, (iv) improving the quality of AF treatment, and (v) personalization of AF management. This report ends with a list of priorities for research in AF patients.
Keywords:Atrial fibrillation / Outcomes / Quality of care / Research / Rate control / Antiarrhythmic drugs / catheter ablation / Anticoagulation / Cardiovascular risk / Bleeding / Research priorities
Source:Europace, 2016, 18, 1, 37-50
- EUTRAF - The European Network for Translational Research in Atrial Fibrillation (EU-261057)
- AFNET, EHRA, BMBF [01GI0204], Leducq Foundation [14 CVD 01]